Skip to main content
. 2017 Oct;8(3):e148–e156. doi: 10.2500/ar.2017.8.0216

Figure 2.

Figure 2.

Effect of MP-AzeFlu (Dymista®) on visual analog scale (VAS) score over time according to (A) allergic rhinitis phenotype and (B) patient age. SAR = seasonal allergic rhinitis; PAR = perennial allergic rhinitis. Data are presented as mean ± standard deviation. **The mean of the last day corresponds to day 16.2.